- Drugs
- Tuesday, 21 Jul 2020
Starch Softgel Capsules Market Breakdown, Development and New Market Opportunities & Forecasts 2027
The starch soft gel capsules are usually derived from natural sources and are used as nutritional supplements for patients suffering from various medical conditions. These soft gel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The soft gel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences. The soft gels are one of the most common and widely used oral dosage forms of pharmaceuticals as well as nutraceuticals. The starch softgel capsules market is expected to witness a huge growth due to increasing availability of vegetarian softgel capsules and rising preference of pharmaceutical and nutraceutical companies toward softgel capsules. However, the market is likely to get impacted by the difficulties in optimizing cellulose/starch for API delivery during the forecast period.
The vegetarian softgel capsules have recently become the product of interest in the market. These capsules are a perfect and viable alternative for people willing to consume non-gelatin capsules. The manufacturers are in a need to differentiate their products and brands from the competition in an increasingly crowded and growing marketplace. Apart from pharmaceutical drug delivery, the vegetarian softgel capsules are usually preferred for filling in nutritional supplements.
Request for sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00011965/
Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH, Sirio Pharma Co., Ltd., and Bahrain Pharma are among the leading companies operating in the starch softgel capsules market.
Based on application, the market is segmented in to health supplements, pharmaceutical, and others. In 2019, the health supplements segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to factors such as capability of softgels to mask odors, elegant in appearance, and easier for swallowing. Moreover, these formulations are considered ideal as they improve the bioavailability and enhance the absorption of essential nutrients. Vitamin and mineral supplements are the commonly preferred starch softgel health supplements. Additionally, increasing awareness among populace regarding the benefits of health and fitness along with high consumption of sports-associated health nutritional supplements are likely to augment the growth of the segment.
The general health industry consumer trend is heading toward a clear increase in the demand for natural products and innovative forms of dosage. The vegetarian softgels have a significant benefit as they do not contain any gelatin material derived from animal waste. These starch softgels satisfy the demand of vegetarians as the capsules can be consumed without the fear of any animal infection or disease. In terms of chemical composition, the vegetarian softgels are chemically stable and have a low-moisture content making them less brittle even in low humidity. The companies engaged in manufacturing halal softgel capsules are receiving halal certification from the Islamic Food and Nutrition Council of America (IFANCA). This is expected to cultivate a significant market for these capsules in Muslim-dominated countries.
Distribution Channel -Based Insights
Based on distribution channel, the starch softgel capsules market is segmented into supermarket and hypermarket, pharmacy and drugstores, and online providers. The pharmacy and drugstore segment held the largest share of the market in 2019. Retail pharmacies in developing countries are emerging as one of the most important sources of advice, included for nutritional supplements and over the counter medicines. The segment is likely to grow over the coming years owing to the increasing trend of a partnership between retailers and large health systems for care assistance to patients leaving the hospitals. However, the online providers segment is anticipated to witness growth at a significant rate during the forecast period.
Strategic Insights
Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategies are commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the starch softgel capsules market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
The Report Segments Global Starch Softgel Capsules Market as Follows:
By Application
- Health Supplements
- Pharmaceutical
- Others
By Distribution Channel
- Supermarket and Hypermarket
- Pharmacy and Drugstore
- Online Provider
Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00011965/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
Malaria Diagnostics Market is expected to reach US$ 1,200.24 million by 2030
Jan 09, 2024
Pet Anthelmintic Drugs Market - Important Changes in Industry Dynamics
Mar 17, 2021
Glenmark Becomes the First Pharmaceutical Company in India to Receive Regulatory Approval for Oral Antiviral Favipiravir, for the Treatment of Mild to Moderate COVID-19
Jun 20, 2020
The ITC Complaint Against Estar Medical in the U.S. Is Withdrawn by Regenlab
Mar 05, 2020
Generic Drugs Market Effect Factors Analysis 2027 – Apotex, Pfizer, Endo Pharmaceuticals, Fresenius Kabi AG, Lupin Pharmaceuticals and Cipla
Mar 15, 2021
Drug Discovery Services Market is expected to reach US$ 56,783.29 million by 2030
Nov 17, 2023
Novartis scraps sale of assets including COVID-19 hopeful to Indis's Aurobindo Pharma
Apr 02, 2020